Wild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic Properties

Simple item page
dc.contributor.authorMcCubrey, James A.
dc.contributor.authorMeher, Akshaya K.
dc.contributor.authorAkula, Shaw M.
dc.contributor.authorAbrams, Stephen L.
dc.contributor.authorSteelman, Linda S.
dc.contributor.authorLaHair, Michelle M.
dc.contributor.authorFranklin, Richard A.
dc.contributor.authorMartelli, Alberto M.
dc.contributor.authorRatti, Stefano
dc.contributor.authorCocco, Lucio
dc.contributor.authorBarbaro, Fulvio
dc.contributor.authorDuda, Przemysław
dc.contributor.authorGizak, Agnieszka
dc.date.accessioned2022-11-02T14:29:48Z
dc.date.available2022-11-02T14:29:48Z
dc.date.issued2022-04-27
dc.identifier.doi10.18632/aging.204038
dc.identifier.issn1945-4589
dc.identifier.urihttp://hdl.handle.net/10342/11681
dc.language.isoen_USen_US
dc.subjectTP53en_US
dc.subjectpancreatic canceren_US
dc.subjectdrug sensitivityen_US
dc.titleWild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic Propertiesen_US
dc.typeArticleen_US
ecu.journal.issue8en_US
ecu.journal.nameAgingen_US
ecu.journal.pages3365-3386en_US
ecu.journal.volume14en_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
McCubreyWildTypeandGainofFunctionMutantTP53canRegulatetheSensitivityofPancreaticCancerCells.pdf
Size:
4.58 MB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Microbiology and Immunology